Prolonged oral etoposide as second-line therapy for platinum-resistant and platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group study (Q33501657)
scientific article published on February 1, 1998
Language:
(P31) (Q13442814)
(P304) 405-410
(P407) (Q1860)
(P433) 2
(P478) 16
(P577) Sunday, February 1, 1998
Sunday, February 1, 1998
(P921) (Q880)
(Q18556145)
(Q5625186)
(Q418817)
(P953) http://intl.jco.org/cgi/content/abstract/16/2/405
https://ascopubs.org/doi/pdfdirect/10.1200/JCO.1998.16.2.405
(P1433) (Q400292)
(P1476) "Prolonged oral etoposide as second-line therapy for platinum-resistant and platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group study" (language: en)
(P2093) P. G. Rose
J. A. Blessing
A. R. Mayer
H. D. Homesley
other details
description scientific article published on February 1, 1998

External Links